You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 127 No. 1, January 2009 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  Letters
 •Online Features
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related article
 •Related letter
 •Similar articles in this journal
 Topic Collections
 •Glaucoma
 •Uveitis
 •Ophthalmological Disorders, Other
 •Drug Therapy
 •Drug Therapy, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

COMMENTS AND OPINIONS
Uveitis Treated With Fluocinolone Acetonide Implants

Francesco Viola, MD; Giovanni Staurenghi, MD; Roberto Ratiglia, MD

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

We read with interest the article by Goldstein and colleagues in the November 2007 issue of the Archives about incidence and management of elevated intraocular pressure (IOP) in patients with uveitis treated with fluocinolone acetonide implants.1 We would like to add a thought to the discussion of the findings.

They reported that 71% of implanted eyes developed elevated IOP requiring antiglaucomatous medication. Nevertheless, in 36.6% of implanted eyes IOP-lowering procedures were performed with a rate of hypotony of 42.5%. Forty-six percent of these eyes manifested hypotony more than 60 days following surgery and 18% more than 1 year after surgery. Thus we may conclude that hypotony occurred in 36% of implanted eyes right after IOP-lowering surgery. In these cases IOP-lowering surgery seems to be the cause of hypotony, rather than the ciliary body damaged by chronic inflammations or implant surgery.

We . . . [Full Text of this Article]


AUTHOR INFORMATION


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Intraocular Pressure in Patients With Uveitis Treated With Fluocinolone Acetonide Implants
Debra A. Goldstein, David G. Godfrey, Anthony Hall, David G. Callanan, Glenn J. Jaffe, P. Andrew Pearson, Dale W. Usner, and Timothy L. Comstock
Arch Ophthalmol. 2007;125(11):1478-1485.
ABSTRACT | FULL TEXT  

RELATED LETTER

Uveitis Treated With Fluocinolone Acetonide Implants—Reply
Debra A. Goldstein, David G. Godfrey, Anthony Hall, David G. Callanan, Glenn J. Jaffe, P. Andrew Pearson, Dale W. Usner, and Timothy L. Comstock
Arch Ophthalmol. 2009;127(1):116.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.